Onderzoeker
Fritz Offner
- Trefwoorden:myeloom, lymfoom, real-world data (RWD), tumor immunotherapie, bispecifieke antliichamen, clinical trials
- Disciplines:Kankerepidemiologie, Toegepaste immunologie, Medische epigenomics, Klinische hematologie, Medische genomics, Diagnostische radiologie, Hematologie, Analyse van next-generation sequence data, Kankerbiologie
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 2000 → 30 sep 2018
Projecten
1 - 5 of 5
- Universeel, kosten-effectief open-source technologieplatform voor lichaamsvloeistof-biopsie met hoge gevoeligheid, gebaseerd op het profileren van het methyloom van circulerend DNA.Vanaf1 jan 2024 → HedenFinanciering: BOF - projecten
- Optimalisatie van CD70-gerichte adoptieve cel therapieVanaf1 nov 2023 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
- Optimaliseren van CD70-specifieke T cel therapie voor soliede en hematologische maligniteitenVanaf1 nov 2022 → 31 okt 2023Financiering: BOF - doctorale mandaten
- Chimerische antigen receptor onconventionele T-celtherapie (CAR-oT) voor de behandeling van solide tumorenVanaf1 nov 2022 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
- Celvrij-nucleïnezuurprofilering in diffuus grootcellig B-cellymfoom: een moleculaire leidraad voor precisiegeneeskundeVanaf1 okt 2022 → 31 okt 2022Financiering: BOF - doctorale mandaten
Publicaties
131 - 140 van 169
- Effect of age on efficacy and safety outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) receiving lenalidomide and low-dose dexamethasone (Rd): the first trial(2014)Volume: 124
Auteurs: Cyrille Hulin, Thierry Facon, Chaim Shustik, Andrew Belch, Maria Teresa Petrucci, Ulrich Duehrsen, Jin Lu, Kevin Song, Philippe Rodon, Brigitte Pegourie, et al.
Aantal pagina's: 1 - Abexinostat (S78454) a histone deacetylase inhibitor, in patients with refractory or relapsed Hodgkin's lymphoma, non-Hodgkin lymphoma and chronic lymphocytic leukaemia: preliminary phase II results(2014)Volume: 99
Auteurs: F Broussais-Guillaumot, F Morschhauser, L Terriou, WS Kim, ST Lim, M Egyed, B Coiffier, E Bachy, MJ Dyer, A Illes, et al.
Pagina's: 141 - 142 - Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis(2014)
Auteurs: Clémentine Sarkozy, Lucile Baseggio, Pierre Feugier, Evelyne Callet-Bauchu, Lionel Karlin, John F Seymour, Laure Lebras, Anne-Sophie Michallet, Fritz Offner, Olivier Dumas, et al.
Pagina's: 659 - 667 - A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies(2014)Volume: 32
Auteurs: Ahmad Awada, Christian D Rolfo, Sylvia Rottey, Laure Ysebrant de Lendonck, Wilfrled A Schroyens, Fritz Offner, Karen Silence, Torsten Dreier, Mahan Moshir, Hans de Heard, et al.
Aantal pagina's: 1 - DUO: a phase 3 trial of the PL3K-delta,gamma inhibitor IPI-145 versus ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphorytic lymphoma(2014)Volume: 32
Auteurs: Ian Flinn, Ulrich Jaeger, Fritz Offner, Florence Cymbalista, Michael Hallek, Federico Callgarls-Capplo, Julio Delgado, Peter Hillman, Matthew Steven Davids, David Donald Wright, et al.
Aantal pagina's: 1 - Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) for relapsed or refractory multiple myeloma (RRMM): overall survival (OS) results of MM-003 after adjustment for Res crossover(2014)Volume: 32
Auteurs: Gareth J Morgan, Jesus San Miguel, Sujith Dhanasiri, Dawn Lee, Antonio Palumbo, Thierry Facon, Mohamed H Zaki, Xin Yu, Lars Axel Sternas, Christian Jacques, et al.
Aantal pagina's: 1 - Ofatumumab (OFA) maintenance prolongs PFS in relapsed CLL: prolong study interim analysis results(2014)Volume: 124
Auteurs: Marinus HJ van Oers, Kazimierz Kuliczkowski, Lukas Smolej, Mario Petrini, Fritz Offner, Sebastian Gorsicki, Mark-David Levin, Ira Gupta, Jennifer Phillips, Vanessa Williams, et al.
Aantal pagina's: 1 - Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone(2014)Volume: 99
Auteurs: G Morgan, JF San Miguel, S Dhanasiri, D Lee, A Palumbo, T Facon, M Zaki, X Yu, L Sternas, C Jacques, et al.
Pagina's: 365 - 366 - Polyfunctional tumor antigen-specific T cells generated in vitro from human CD34 positive precursor cells transduced to express T cell receptor alpha beta chains fused to CD28-CD3 zeta signaling cassette(2014)Volume: 124
Auteurs: Yasmine Van Caeneghem, Glenn Goetgeluk, Sylvia Snauwaert, Fritz Offner, Reno Debets, Tessa Kerre, Bart Vandekerckhove
Aantal pagina's: 1 - SF3B1 mutations and outcome in CLL patients treated with chlorambucil (CHL) or ofatumumab-CHL (O plus CHL): results from the phase III study complement 1 (OMB110911)(2014)Volume: 99
Auteurs: E Tausch, C Galler, RF Schlenk, P Hillmen, Fritz Offner, A Janssens, K Govindbabu, S Grosicki, J Mayer, P Panagiotidis, et al.
Pagina's: 522 - 523
Gelinkte datasets
1 - 1 van 1